| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
13.2 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
13.2 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
13.2 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
13.170 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
13.170 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
SPTAN1 |
IPI00413728 |
13.170 |
Evidence |
|
| LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
13.120 |
Evidence |
|
| DAPP1 |
IPI00004301 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
13.120 |
Evidence |
|
| TCOF1 |
IPI00298696 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
13.120 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
13.120 |
Evidence |
|
| ARHGDIB |
ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
13.120 |
Evidence |
|
| CCL11 |
CCL11, SCYA11: Eotaxin precursor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
13.120 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
13.120 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
13.120 |
Evidence |
|
| SP100 |
IPI00011675 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
13.120 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
13.120 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
13.120 |
Evidence |
|
| XRCC6 |
XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
13.120 |
Evidence |
|
| ALOX5 |
ALOX5, LOG5: Arachidonate 5-lipoxygenase |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
13.120 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
FCGR2A |
FCGR2A: Fc of IgG, low affinity IIa, receptor |
13.120 |
Evidence |
|
| IL6 |
IL6, IFNB2: Interleukin-6 precursor |
LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
13.120 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
HAMP |
HAMP, HEPC, UNQ487/PRO1003, LEAP1: Hepcidin precursor |
13.120 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
13.120 |
Evidence |
|
| TTR |
TTR, PALB: Transthyretin precursor |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
13.120 |
Evidence |
|
| APOA2 |
APOA2: Apolipoprotein A-II precursor |
TTR |
TTR, PALB: Transthyretin precursor |
13.120 |
Evidence |
|